TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 1660514

Group type: EXPERIMENTAL
Intervention: Human alpha-ANP infusion at 0.01 micrograms/kg per min
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo ANP infusion
Number of subjects: 6
Study: 7120015

Group type: EXPERIMENTAL
Intervention: Mood state of elation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Mood state of depression
Number of subjects: 0

Group type: COMPARATOR
Intervention: Ineffective mood inductions
Number of subjects: 0
Study: 30526074

Group type: EXPERIMENTAL
Intervention: Group executive function training (GEFT)
Number of subjects: 81

Group type: COMPARATOR
Intervention: Social skills training (SST)
Number of subjects: 81
Study: 30782719

Group type: EXPERIMENTAL
Intervention: Multimodal integrative intervention incorporating relaxation, guided imagery, and moderate pressure touch massage for up to five consecutive days.
Number of subjects: 104

Group type: COMPARATOR
Intervention: Standard care and a sham intervention.
Number of subjects: 104
Study: 27842383

Group type: EXPERIMENTAL
Intervention: Ledipasvir (90 mg) and sofosbuvir (400 mg) for 12 weeks
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: Ledipasvir (90 mg) and sofosbuvir (400 mg) for 24 weeks
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: Adverse events overall
Number of subjects: 114
Study: 25145934

Group type: EXPERIMENTAL
Intervention: miR‐21 expression in glomerular fractions
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: miR‐21 deficiency in TGF‐β(1)‐transgenic mice
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Inhibition of miR‐21 in cultured podocytes
Number of subjects: 48
Study: 23963786

Group type: EXPERIMENTAL
Intervention: PA + WL (n=98)
Number of subjects: 288

Group type: COMPARATOR
Intervention: PA-only (n=97)
Number of subjects: 288

Group type: COMPARATOR
Intervention: SA control (n=93)
Number of subjects: 288
Study: 21937805

Group type: EXPERIMENTAL
Intervention: Noninvasive limb ischemic preconditioning (NIPC)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 32
Study: 19539316

Group type: EXPERIMENTAL
Intervention: Continuous sutures
Number of subjects: 80

Group type: COMPARATOR
Intervention: Interrupted sutures
Number of subjects: 80
Study: 17709451

Group type: EXPERIMENTAL
Intervention: Folic acid (5 mg) and vitamin B-12 (1.25 mg) supplementation
Number of subjects: 86

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 86
Study: 12612213

Group type: EXPERIMENTAL
Intervention: Supplemental glycerol at 5 micromol/kg x min
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Supplemental glycerol at 10 micromol/kg x min
Number of subjects: 20

Group type: COMPARATOR
Intervention: Glucose alone (control group)
Number of subjects: 20
Study: 10562586

Group type: EXPERIMENTAL
Intervention: Hydrogen peroxide enhanced ultrasound (US)-fistulography
Number of subjects: 17

Group type: COMPARATOR
Intervention: Conventional x ray fistulogram
Number of subjects: 17

Group type: COMPARATOR
Intervention: Barium radiography
Number of subjects: 17
Study: 8733881

Group type: EXPERIMENTAL
Intervention: TSH screening program using a supersensitive TSH assay
Number of subjects: 1880

Group type: EXPERIMENTAL
Intervention: Full thyroid function testing
Number of subjects: 1880

Group type: EXPERIMENTAL
Intervention: Full assessment of 600 subjects
Number of subjects: 1880

Group type: EXPERIMENTAL
Intervention: Assessment of antithyroid antibodies
Number of subjects: 1880

Group type: EXPERIMENTAL
Intervention: Age-related changes in free T4 and free T3
Number of subjects: 1880

Group type: EXPERIMENTAL
Intervention: Age-related changes in free T3/free T4 ratio
Number of subjects: 1880
Study: 1860625

Group type: EXPERIMENTAL
Intervention: Ranitidine
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Pirenzepine
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Food ingestion
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Sham feeding
Number of subjects: 24
Study: 7159691

Group type: EXPERIMENTAL
Intervention: Chlorbutol (oral administration)
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Chlorbutol (second dose)
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Chlorbutol (urinary recovery)
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Chlorbutol (in vitro stability)
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Chlorbutol (multiple doses)
Number of subjects: 4
Study: 30955351

Group type: EXPERIMENTAL
Intervention: Reading vignettes describing fictitious older adults with memory impairment
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Reading vignettes that included descriptions of BPSD
Number of subjects: 200

Group type: COMPARATOR
Intervention: Control group (responded to questionnaire without reading any vignette)
Number of subjects: 200
Study: 31104167

Group type: EXPERIMENTAL
Intervention: Baseline plasma 25-hydroxyvitamin D3 (25(OH)D) levels
Number of subjects: 535

Group type: EXPERIMENTAL
Intervention: Genetic risk score based on 25(OH)D-associated SNPs
Number of subjects: 535

Group type: EXPERIMENTAL
Intervention: 25(OH)D levels and rs12785878 genotype in DHCR7
Number of subjects: 535
Study: 29023839

Group type: EXPERIMENTAL
Intervention: Salud-100 intervention (all families received the intervention)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Salud-50 intervention (families either received booklets or the intervention)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Control group (families received booklets on healthy eating and exercise)
Number of subjects: 27
Study: 25921544

Group type: EXPERIMENTAL
Intervention: 33 °C treatment group
Number of subjects: 939

Group type: EXPERIMENTAL
Intervention: 36 °C treatment group
Number of subjects: 939
Study: 22990757

Group type: EXPERIMENTAL
Intervention: Dang Gui Buxue Tang (DBT) 3.0 g/day
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Dang Gui Buxue Tang (DBT) 6.0 g/day
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Dang Gui Buxue Tang (DBT) 1.5 g/day
Number of subjects: 60
Study: 21724703

Group type: EXPERIMENTAL
Intervention: Homozygosity of the rs1800802 minor allele
Number of subjects: 376

Group type: COMPARATOR
Intervention: Serum MGP concentrations
Number of subjects: 376
Study: 20376999

Group type: EXPERIMENTAL
Intervention: 0.5% bupivacaine (2 mg/kg), epinephrine (100 microg), and fentanyl (2.5 microg/kg)
Number of subjects: 40

Group type: COMPARATOR
Intervention: 0.5% bupivacaine (2 mg/kg) and epinephrine (100 microg)
Number of subjects: 40
Study: 16571906

Group type: EXPERIMENTAL
Intervention: Normal stance condition
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Resist influence condition
Number of subjects: 0

Group type: COMPARATOR
Intervention: Eyes closed condition
Number of subjects: 0
Study: 14988279

Group type: EXPERIMENTAL
Intervention: Transdermal 17‐beta‐estradiol
Number of subjects: 673
Study: 10360656

Group type: EXPERIMENTAL
Intervention: 5-fluorouracil (5-FU) combined with human interferon-beta (IFN-beta)
Number of subjects: 49

Group type: COMPARATOR
Intervention: 5-fluorouracil (5-FU) alone
Number of subjects: 49
Study: 8951752

Group type: EXPERIMENTAL
Intervention: Hydrogel‐coated balloon catheters delivered with heparin coating (n = 33)
Number of subjects: 59

Group type: COMPARATOR
Intervention: Hydrogel‐coated balloon catheters without heparin coating (n = 26)
Number of subjects: 59
Study: 2019820

Group type: EXPERIMENTAL
Intervention: Chiropractic adjustments
Number of subjects: 171
Study: 6177709

Group type: EXPERIMENTAL
Intervention: Intravenous immune globulin (IGIV) at a dose of 20 ml/kg, administered twenty-four hours post transplantation and then weekly for 10 weeks.
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Intravenous immune globulin (IGIV)
Number of subjects: 13
Study: 30606135

Group type: EXPERIMENTAL
Intervention: C-DIRECT intervention (nurse-led intervention based on motivational interviewing and self-management)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: C-DIRECT intervention
Number of subjects: 44

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: C-DIRECT intervention and Usual care
Number of subjects: 44
Study: 30304745

Group type: EXPERIMENTAL
Intervention: ECG self-monitoring using mHealth technology for 6 months
Number of subjects: 13
Study: 26956161

Group type: EXPERIMENTAL
Intervention: Real acupuncture, three times a week for 4 weeks
Number of subjects: 88

Group type: COMPARATOR
Intervention: Sham acupuncture (superficial insertion at irrelevant acupuncture points), three times a week for 4 weeks
Number of subjects: 88
Study: 25085836

Group type: EXPERIMENTAL
Intervention: Finasteride and placebo treatment arms
Number of subjects: 3377

Group type: COMPARATOR
Intervention: Placebo arm
Number of subjects: 3377

Group type: EXPERIMENTAL
Intervention: Combined treatment arms
Number of subjects: 3377

Group type: EXPERIMENTAL
Intervention: Men ≥65 years
Number of subjects: 3377

Group type: EXPERIMENTAL
Intervention: Men 55-64 years
Number of subjects: 3377
Study: 23091707

Group type: EXPERIMENTAL
Intervention: Meal replacements (MRs) - 2 MR/day for 3 months and 1 MR/day for 3 months
Number of subjects: 120

Group type: COMPARATOR
Intervention: Diet book (control)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Meal replacements (MRs) - intention-to-treat analysis
Number of subjects: 120

Group type: COMPARATOR
Intervention: Diet book (control) - intention-to-treat analysis
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Meal replacements (MRs)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 120
Study: 20570122

Group type: EXPERIMENTAL
Intervention: Genistein aglycone (54 mg/day)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Norethisterone acetate (10 mg/day on days 16-25 of the menstrual cycle)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 56
Study: 18043573

Group type: EXPERIMENTAL
Intervention: 2‐octyl‐cyanoacrylate (2‐OCA) glue
Number of subjects: 310

Group type: EXPERIMENTAL
Intervention: Non‐reabsorbable intradermal suture
Number of subjects: 310

Group type: COMPARATOR
Intervention: Metallic clips
Number of subjects: 310
Study: 16086602

Group type: EXPERIMENTAL
Intervention: Mometasone furoate nasal spray (MFNS)
Number of subjects: 100
Study: 12122096

Group type: EXPERIMENTAL
Intervention: CMF followed by tamoxifen (20 mg/day, orally for 57 months)
Number of subjects: 1669

Group type: COMPARATOR
Intervention: Tamoxifen alone (20 mg/day, orally for 60 months)
Number of subjects: 1669
Study: 12024388

Group type: EXPERIMENTAL
Intervention: Growth hormone therapy
Number of subjects: 0
Study: 7675685

Group type: EXPERIMENTAL
Intervention: Priority ranking of research topics
Number of subjects: 2178
Study: 31784410

Group type: EXPERIMENTAL
Intervention: Stepping Stones and Creating Futures intervention
Number of subjects: 1322

Group type: COMPARATOR
Intervention: Wait-list control
Number of subjects: 1322
Study: 31455407

Group type: EXPERIMENTAL
Intervention: C5 to C7 nerve root block
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: C5 to C8 nerve root block
Number of subjects: 74
Study: 27084245

Group type: EXPERIMENTAL
Intervention: PSA screening
Number of subjects: 7539

Group type: COMPARATOR
Intervention: Unscreened men
Number of subjects: 7539
Study: 26305648

Group type: EXPERIMENTAL
Intervention: Physical activity program (n = 818)
Number of subjects: 1635

Group type: COMPARATOR
Intervention: Health education program (n = 817)
Number of subjects: 1635

Group type: EXPERIMENTAL
Intervention: Physical activity group (n = 307, aged 80 or older)
Number of subjects: 1635

Group type: EXPERIMENTAL
Intervention: Physical activity group (n = 328, poorer baseline physical performance)
Number of subjects: 1635

Group type: EXPERIMENTAL
Intervention: Physical activity group
Number of subjects: 1635

Group type: COMPARATOR
Intervention: Health education group
Number of subjects: 1635
Study: 27536443

Group type: EXPERIMENTAL
Intervention: LCTZ plus FFNS (combination group)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: LCTZ plus FFNS placebo (monotherapy group)
Number of subjects: 42

Group type: COMPARATOR
Intervention: LCTZ placebo plus FFNS placebo (placebo group)
Number of subjects: 42
Study: 21778153

Group type: EXPERIMENTAL
Intervention: Heavy smokers who abstained from smoking for 12 hr
Number of subjects: 54

Group type: COMPARATOR
Intervention: Heavy smokers who smoked as usual
Number of subjects: 54
Study: 19963158

Group type: EXPERIMENTAL
Intervention: 400 mg pequi oil capsules for 14 days
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 16930785

Group type: COMPARATOR
Intervention: Midazolam
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Midazolam with Remifentanil
Number of subjects: 40
Study: 15472177

Group type: EXPERIMENTAL
Intervention: Oxandrolone (20 mg/d; n = 20)
Number of subjects: 32
Study: 11720432

Group type: EXPERIMENTAL
Intervention: Palliative care intervention
Number of subjects: 395
Study: 9791142

Group type: EXPERIMENTAL
Intervention: Zidovudine and Lamivudine
Number of subjects: 378

Group type: EXPERIMENTAL
Intervention: Zidovudine and Indinavir
Number of subjects: 378

Group type: COMPARATOR
Intervention: Triple-drug therapy (Zidovudine, Lamivudine, and Indinavir)
Number of subjects: 378
Study: 7820985

Group type: EXPERIMENTAL
Intervention: 900 mg/day telmestein
Number of subjects: 20

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 20
Study: 3059703

Group type: EXPERIMENTAL
Intervention: pirenzepine 50 mg b.i.d. (n = 24)
Number of subjects: 43

Group type: COMPARATOR
Intervention: cimetidine 400 mg b.i.d. (n = 19)
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: pirenzepine 50 mg b.i.d. or cimetidine 400 mg b.i.d.
Number of subjects: 43
Study: 31963904

Group type: EXPERIMENTAL
Intervention: Fundamental motor skill focus (FMS)
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: Physical activity focus (PA)
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: FMS and PA (FMS + PA)
Number of subjects: 98

Group type: COMPARATOR
Intervention: Control
Number of subjects: 98
Study: 30328064

Group type: EXPERIMENTAL
Intervention: Self-etch primed sealant (Beautisealant, Shofu)
Number of subjects: 81

Group type: COMPARATOR
Intervention: Conventional etch and rinse sealant (Seal it, Spident)
Number of subjects: 81
Study: 29098263

Group type: EXPERIMENTAL
Intervention: Pain management intervention measures
Number of subjects: 100

Group type: COMPARATOR
Intervention: Conventional nursing care (Control)
Number of subjects: 100
Study: 26245807

Group type: EXPERIMENTAL
Intervention: Soy isoflavone oral supplements (2 doses of a genistein-rich soy supplement and 3 doses of mixed isoflavones)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Risedronate (bisphosphonate)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Genistein at 52.85 mg/d
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Most effective soy intervention (105.23 mg total isoflavones/d)
Number of subjects: 24
Study: 23864314

Group type: EXPERIMENTAL
Intervention: Subthalamic nuclei deep brain stimulation (STN‐DBS)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Levodopa administration
Number of subjects: 19

Group type: COMPARATOR
Intervention: Stimulation off/medication off (control condition)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Chronic STN‐DBS
Number of subjects: 19
Study: 20506561

Group type: EXPERIMENTAL
Intervention: RA scores (DAS, DAS in 28 joints, Simplified Disease Activity Index, Clinical Disease Activity Index)
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: JADAS (10-, 27-, and 71-joint counts)
Number of subjects: 97
Study: 18192341

Group type: EXPERIMENTAL
Intervention: Bachmann's bundle (BB) area
Number of subjects: 139

Group type: COMPARATOR
Intervention: Right atrial appendage (RAA) area
Number of subjects: 139
Study: 16344495

Group type: EXPERIMENTAL
Intervention: Thalidomide treatment
Number of subjects: 7

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 7
Study: 14736007

Group type: EXPERIMENTAL
Intervention: Renal artery stent placement with medication (statins, anti-hypertensive drugs, antiplatelet therapy)
Number of subjects: 140

Group type: COMPARATOR
Intervention: Medication alone (statins, anti-hypertensive drugs, antiplatelet therapy)
Number of subjects: 140
Study: 11040223

Group type: EXPERIMENTAL
Intervention: Dinamap oscillometric blood pressure monitor
Number of subjects: 1808

Group type: COMPARATOR
Intervention: random‐zero sphygmomanometer
Number of subjects: 1808
Study: 8651094

Group type: EXPERIMENTAL
Intervention: Ramipril (1.25 to 20 mg/day)
Number of subjects: 1055

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1055
Study: 1740589

Group type: EXPERIMENTAL
Intervention: Nasal provocation with allergen
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 6384250

Group type: EXPERIMENTAL
Intervention: 60% CHO diet with 15% sucrose (60-15%)
Number of subjects: 10

Group type: COMPARATOR
Intervention: 60% CHO diet with 13% sucrose (60-13%)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 40% CHO diet with 9% sucrose (40-9%)
Number of subjects: 10

Group type: COMPARATOR
Intervention: 40% CHO diet with 13% sucrose (40-13%)
Number of subjects: 10
Study: 31529662

Group type: EXPERIMENTAL
Intervention: Condom balloon tamponade (CBT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 0
Study: 28644716

Group type: COMPARATOR
Intervention: Water (W)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Carbohydrate (CHO)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Caffeine + Carbohydrate (CAF+CHO)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Caffeine (CAF)
Number of subjects: 14
Study: 27542833

Group type: EXPERIMENTAL
Intervention: Promotion of appropriate complementary feeding practices
Number of subjects: 611

Group type: EXPERIMENTAL
Intervention: Child's age (12-17 and 18-23 months)
Number of subjects: 611

Group type: EXPERIMENTAL
Intervention: Educational level of mother (primary and secondary and above schools)
Number of subjects: 611

Group type: EXPERIMENTAL
Intervention: Smaller family size
Number of subjects: 611
Study: 24844734

Group type: EXPERIMENTAL
Intervention: Web-based parenting skills intervention with live coaching
Number of subjects: 7

Group type: COMPARATOR
Intervention: Internet resources on brain injury
Number of subjects: 7
Study: 22409354

Group type: EXPERIMENTAL
Intervention: 1,064 nm laser-assisted liposuction and minimally invasive skin tightening
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 1,319 nm laser-assisted liposuction and minimally invasive skin tightening
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 1,064/1,319 nm laser-assisted liposuction and minimally invasive skin tightening
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Combination of all treatments (1,064 nm, 1,319 nm, and blended)
Number of subjects: 12
Study: 20130150

Group type: EXPERIMENTAL
Intervention: Preference for abstinence
Number of subjects: 0

Group type: COMPARATOR
Intervention: Preference for non-abstinence
Number of subjects: 0
Study: 17035939

Group type: EXPERIMENTAL
Intervention: Very low protein diet (VLPD) supplemented with ketoanalogs (0.35 g/kg/day)
Number of subjects: 110

Group type: COMPARATOR
Intervention: Low protein diet (LPD, 0.60 g/kg/day)
Number of subjects: 110

Group type: COMPARATOR
Intervention: Free diet (FD)
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Very low protein diet (VLPD)
Number of subjects: 110
Study: 15267124

Group type: EXPERIMENTAL
Intervention: Weak/Intentional
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Strong/Intentional
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Weak/Incidental
Number of subjects: 0

Group type: COMPARATOR
Intervention: Strong/Incidental
Number of subjects: 0
Study: 11381492

Group type: EXPERIMENTAL
Intervention: Thymosin alpha-1 (TA1)
Number of subjects: 357

Group type: COMPARATOR
Intervention: Thymosin alpha-1 (TA1) for 6 months
Number of subjects: 357

Group type: COMPARATOR
Intervention: Thymosin alpha-1 (TA1) for 12 months
Number of subjects: 357

Group type: COMPARATOR
Intervention: Combination TA1 and IFN-alpha 2b
Number of subjects: 357
Study: 9815011

Group type: EXPERIMENTAL
Intervention: Alcohol (48 g)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 8017602

Group type: EXPERIMENTAL
Intervention: Nasal cannulae
Number of subjects: 20

Group type: COMPARATOR
Intervention: Complete nasal obstruction
Number of subjects: 20
Study: 2582983

Group type: EXPERIMENTAL
Intervention: Mental stress (induced by solving anagrams and doing mental arithmetic for 60 min)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Mental stress
Number of subjects: 12
Study: 779692

Group type: EXPERIMENTAL
Intervention: Oral disopyramide administered during 7 days
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 31477152

Group type: EXPERIMENTAL
Intervention: Aspirin (162 mg daily for 2 weeks)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Pravastatin (40 mg daily for 2 weeks)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Combined treatment (Aspirin 162 mg and Pravastatin 40 mg daily for 2 weeks)
Number of subjects: 25
Study: 28314622

Group type: EXPERIMENTAL
Intervention: Transcatheter aortic valve replacement (TAVR)
Number of subjects: 90
Study: 27049526

Group type: EXPERIMENTAL
Intervention: 25(OH)D concentrations ≥40 ng/ml
Number of subjects: 2304

Group type: COMPARATOR
Intervention: 25(OH)D concentrations <20 ng/ml
Number of subjects: 2304
Study: 24783469

Group type: EXPERIMENTAL
Intervention: Continuous positive airway pressure therapy (CPAP) for 24 weeks
Number of subjects: 117
Study: 23094120

Group type: EXPERIMENTAL
Intervention: Praziquantel (PZQ) treatment
Number of subjects: 369
Study: 19232573

Group type: EXPERIMENTAL
Intervention: Mindfulness-Based Cognitive Therapy (MBCT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Matched controls
Number of subjects: 0
Study: 18089249

Group type: EXPERIMENTAL
Intervention: Downward social comparison
Number of subjects: 0

Group type: COMPARATOR
Intervention: Upward social comparison
Number of subjects: 0

Group type: COMPARATOR
Intervention: No comparison
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Appearance self-schema priming
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Non-appearance schema priming
Number of subjects: 0
Study: 15204676

Group type: EXPERIMENTAL
Intervention: Office-based methadone maintenance
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Focus group discussions
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Chart audits and mentoring
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Processes of care
Number of subjects: 0
Study: 11337315

Group type: EXPERIMENTAL
Intervention: Saw Palmetto Herbal Blend (SPHB)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Finasteride
Number of subjects: 66

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 66